John Hennegan

About John Hennegan

John is a Founding Partner of Shore Capital, a lower middle market private equity firm based in Chicago. Shore’s strategy is to support management to grow faster with less risk, through access to capital, world-class board and operational resources, and unmatched networking, development, and shared learnings across the portfolio. John co-heads the firm\'s Advantage Fund is primarily responsible for the sourcing and evaluation of healthcare investment opportunities and operating executives. Additionally, John serves as Chairman of BrightView, Empower Aesthetics, PhaseWell Research, Point C, Southern Orthodontic Partners, and Transformations Care Network where he actively works with management to identify and implement new growth initiatives. John previously served as Chairman of Behavioral Innovations, Column Health, and Florida Autism Center. He is a Director for Therapy Partners Group, OMS 360, and AA Medical as well as a past Director of ClearPath Diagnostics, Fast Pace Urgent Care, and The Stepping Stones Group.Prior to founding Shore, John worked at Henry Crown & Company, the private investing firm for the Crown family of Chicago. While at Henry Crown, John completed the acquisition of Formax (now part of Provisur Technologies) and worked with management to identify and pursue multiple add-on acquisitions. Prior to joining Henry Crown, John worked in Citigroup\'s investment banking division in New York and Chicago providing merger and strategic advisory services for companies across a diverse set of industries.Outside of the office, John is a member of the Shedd Aquarium President\'s Council and an avid golfer.John earned his M.B.A. with Distinction from the Kellogg School of Management at Northwestern University where he was an Austin Scholar and received a B.S. with Honors from the University of Illinois.

Experience

1. Founding Partner

   Shore Capital Partners

   Jan 2009 — Present

   Shore Capital, a Chicago-based private equity firm with offices in Nashville, is an investor in lower middle market companies in the Healthcare, Food and Beverage, Business Services, Industrial, and Real Estate industries. Shore’s strategy is to support management partners to grow faster with less risk through access to capital, world-class board and operational resources, and unmatched networking, development, and shared learnings across the portfolio. From 20••••24, Shore received recognition from Inc Magazine as a 5x Top Founder Friendly Investor and by Pitchbook Research for leading U.S. Private Equity deal volume for the past 10 years, from 20••••24. Shore targets investments in proven, successful private companies with superior management teams, stable cash flow, and significant potential to grow through industry consolidation and organic growth to generate value for shareholders. Shore has approximately $12.5 billion of assets under management and in additional investment platforms to which it provides business and operational consulting services. For more information on these awards and investment platforms, please visit:

Education

• Gies College of Business - University of Illinois Urbana-Champaign

  B.S., Finance

• Northwestern University - Kellogg School of Management

  MBA with Distinction